Open AccessA Number-Needed-to-Treat Analysis of the Use of Respiratory Syncytial Virus Immune Globulin to Prevent Hospitalization
Author(s) -
James M. Robbins,
J. Mick Tilford,
R. F. Jacobs,
J. Gary Wheeler,
Stephen R. Gillaspy,
Gordon E. Schutze
Publication year - 1998
Publication title -
archives of pediatrics and adolescent medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3628
pISSN - 1072-4710
DOI - 10.1001/archpedi.152.4.358
Subject(s) - bronchopulmonary dysplasia , medicine , confidence interval , randomized controlled trial , pediatrics , intensive care medicine , pregnancy , gestational age , genetics , biology
To estimate how many infants in selected high-risk subgroups would require treatment with respiratory syncytial virus immune globulin (RSV-IG) to avoid 1 hospital admission and to determine whether this is economically justified.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom